VISTAGEN THERAPEUTICS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
VISTAGEN THERAPEUTICS, INC. (VTGN) had Deferred Tax Liabilities, Property, Plant and Equipment of $0 as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-06-15
- 2026-03-31: Deferred Tax Liabilities, Property, Plant and Equipment $0.00.
- 2025-03-31: Deferred Tax Liabilities, Property, Plant and Equipment $12.00K.
- 2024-03-31: Deferred Tax Liabilities, Property, Plant and Equipment $20.00K.
- 2023-03-31: Deferred Tax Liabilities, Property, Plant and Equipment $5.00K; Deferred Tax Liabilities, Property, Plant and Equipment as first filed $4.80K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2026-03-31 | $0.00 10-K · filed 2026-06-15 | |
| 2025-03-31 | $12.00K 10-K · filed 2026-06-15 | |
| 2024-03-31 | $20.00K 10-K · filed 2025-06-17 | |
| 2023-03-31 | $5.00K 10-K · filed 2024-06-11 | $4.80K 10-K · filed 2023-06-28 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |